Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Ten Janus Family Kinases (JAK) Inhibitors are now approved to treat a wide, and still expanding, variety of disorders driven by both innate and adaptive immune mechanisms
Currently, numerous clinical trials are ongoing for systemic lupus erythematosus, Sjogren syndrome, sarcoidosis, psoriasis, hidradenitis suppurativa, asthma and malignancies
…